In silico analysis of endocrine‐disrupting potential of triclosan, bisphenol A, and their analogs and derivatives

Abstract

AbstractOwning to the increasing body of evidence about the ubiquitous exposure to endocrine disruptors (EDCs), particularly bisphenol A (BPA), and associated health effects, BPA has been gradually substituted with insufficiently tested structural analogs. The unmanaged excessive use of antimicrobial agents such as triclosan (TCS) during the COVID‐19 outbreak has also raised concerns about its possible interferences with hormonal functions. The similarity of BPA and estradiol, as well as TCS and non‐steroidal estrogens, imply that endocrine‐disrupting properties of their analogs could be predicted based on the chemical structure. Hence, this study aimed to evaluate the endocrine‐disrupting potential of BPA substitutes as well as TCS derivatives and degradation/biotransformation metabolites, in comparison to BPA and TCS based on their molecular properties, computational predictions of pharmacokinetics and binding affinities to nuclear receptors. Based on the obtained results several under‐researched BPA analogs exhibited higher binding affinities for nuclear receptors than BPA. Notable analogs included compounds detected in receipts (DD‐70, BTUM‐70, TGSA, and BisOPP‐A), along with a flame retardant, BDP. The possible health hazards linked to exposure to TCS and its mono‐hydroxylated metabolites were also found. Further research is needed in order to elucidate the health impacts of these compounds and promote better regulation practices.